Glenmark Pharmaceuticals Limited has informed the Exchange regarding Appointment of Mr. Anurag Mantri as Senior Management of the company w.e.f. April 07, 2025.
GLENMARK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Glenmark Pharmaceuticals has informed the stock exchange about the appointment of Mr. Anurag Mantri to a Senior Management position, effective April 7, 2025. The company has not disclosed further details such as his exact designation, prior work history, or the role being filled. Such appointments under the Senior Management category typically include key functional leadership positions within the firm. The announcement was made via a regulatory filing to the NSE as required under SEBI listing norms for changes in key managerial personnel.
Routine leadership update with no immediate impact on shareholders. Investors may want to watch for further clarity on Mr. Mantri's role and responsibilities to gauge any strategic shifts.